Table 1 Baseline characteristics of the study population.

From: Gamma-glutamyl-transpeptidase to platelet ratio is not superior to APRI,FIB-4 and RPR for diagnosing liver fibrosis in CHB patients in China

Characteristic

CHB

(n = 256)

Median age (years) (IQR)

38.0 (29.0, 46.0)

Male (%)

204 (79.7)

Median ALT (IU/L) (IQR)

42.0 (28.0, 79.8)

Median AST (IU/L) (IQR)

36.0 (26.0, 58.5)

Median GGT (IU/L) (IQR)

38.0 (23.0, 78.8)

Median Neutrophils (×109/L) (IQR)

2.9 (2.2, 3.6)

Median Lymphocytes (×109/L) (IQR)

1.7 (1.4, 2.1)

Median Hb (g/L) (IQR)

145.0 (132.3, 154.0)

Median PLT (×109/L) (IQR)

148.5 (110.5, 190.5)

Median RDW (%) (IQR)

12.0 (11.5, 12.6)

Tbil (μmol/L) (IQR)

15.1 (11.6, 21.5)

HBeAg positive (%)

142 (55.5)

Median size of liver biopsy (cm) (IQR)

1.3 (1.0, 1.5)

Fibrosis stages

 F0 (%)

34 (13.3)

 F1 (%)

41 (16.0)

 F2 (%)

32 (12.5)

 F3 (%)

66 (25.8)

 F4 (%)

83 (32.4)

Median HBV DNA level (log10 copies/mL) (IQR)

5.3 (3.3, 6.8)

  1. ALT, alanine aminotransferase; AST, aspartate aminotransferase; CHB, chronic hepatitis B; GGT, gamma-glutamyl transferase; Hb, hemoglobin; IQR, interquartile range; PLT, platelets; RDW, red cell distribution width; Tbil, total bilirubin.
Back to article page